Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Other Non-Current Assets (2014 - 2026)

Viking Therapeutics' (VKTX) quarterly Other Non-Current Assets came in at $211000.0 in Q2 2026, up 358.7% year-over-year from $46000.0 in Q2 2025, and up 539.39% quarter-over-quarter from $33000.0 in Q1 2026.

Analysis

Viking Therapeutics (VKTX) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Other Non-Current Assets across 13 years of filings, most recently posting $211000.0 for Q2 2026.

  • In Q2 2026, Other Non-Current Assets rose 358.7% year-over-year to $211000.0; the TTM figure through Jun 2026 stood at $211000.0 (up 358.7% YoY), while the FY2025 annual figure was $46000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets came in at $211000.0 for Q2 2026 at Viking Therapeutics, up from $33000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $211000.0 in Q2 2026 to a low of $33000.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $47222.2, with a median of $33000.0 recorded in 2022.
  • The largest YoY upside for Other Non-Current Assets was 358.7% in 2026 against a maximum downside of 28.26% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $33000.0 in 2022, then changed by 0.0% to $33000.0 in 2023, then jumped by 39.39% to $46000.0 in 2024, then changed by 0.0% to $46000.0 in 2025, then soared by 358.7% to $211000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $211000.0 in Q2 2026, $33000.0 in Q1 2026, and $46000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 14.27 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 10.73 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 4.75 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.25 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn - 211,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 211,000.00
Mar 31, 2026 33,000.00
Dec 31, 2025 46,000.00
Sep 30, 2025 46,000.00
Jun 30, 2025 46,000.00
Mar 31, 2025 46,000.00
Dec 31, 2024 46,000.00
Sep 30, 2024 46,000.00
Jun 30, 2024 33,000.00
Mar 31, 2024 33,000.00
Dec 31, 2023 33,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 33,000.00
Mar 31, 2023 33,000.00
Dec 31, 2022 33,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 33,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 33,000.00
Dec 31, 2020 29,000.00
API Access

Viking Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY